A New Era of Cell Line Development on the Beacon^® Optofluidic Platform

A New Chapter in Cell Line Development Is Coming

Cell line development requires balancing speed with confidence, identifying the best clones for therapeutic molecule production while maintaining the robust, automated processes needed to move programs forward quickly and efficiently.

Now, something new is coming to Beacon^® Optofluidic platform

Join us for a special webinar as we reveal what’s next for cell line development (CLD) on the Beacon platform. For years, the Beacon technology has helped CLD teams reduce development timelines while selecting the most productive clones by combining high-throughput clone selection with early insights into productivity, product quality, and stability. Now, we’re taking the next step in making these powerful capabilities more accessible to cell line development teams.

Be among the first to see what’s coming and discover how the next evolution of Beacon technology can help you:

• Compress CLD timelines while selecting the right clones by assessing product quality, productivity, and stability within days to weeks, instead of months later
• Thoroughly characterize clones at high throughput with a vast portfolio of assays to ensure high-performing clone selection while generating data to power your AI pipelines
• Confidently submit IND filings to regulators with superior end-to-end monoclonality assurance
• Scale your CLD process with robust and reproducible automated cell line development workflows

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet finibus nulla. Integer a ligula viverra, dapibus mi eu, volutpat purus. Praesent posuere et risus nec bibendum. Curabitur quam nibh, maximus lobortis tortor ac, congue pulvinar augue. Pellentesque pretium mauris eget imperdiet laoreet.

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet finibus nulla. Integer a ligula viverra, dapibus mi eu, volutpat purus. Praesent posuere et risus nec bibendum. Curabitur quam nibh, maximus lobortis tortor ac, congue pulvinar augue. Pellentesque pretium mauris eget imperdiet laoreet.

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet finibus nulla. Integer a ligula viverra, dapibus mi eu, volutpat purus. Praesent posuere et risus nec bibendum. Curabitur quam nibh, maximus lobortis tortor ac, congue pulvinar augue. Pellentesque pretium mauris eget imperdiet laoreet.